Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134697) titled 'Comparative the Effects of Tegileridine Fumarate and Sufentanil on Postoperative Pain and Recovery Quality after Laparoscopic Total Hysterectomy' on Oct. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Anqing Municipal Hospital
Condition:
Laparoscopic total hysterectomy
Intervention:
Tegenerin Group (T):Intravenous injection of Tegenerin 1 mg 15 min before the end of surgery, immediately connected to a patient-controlled analgesia pump at the end of surgery (Tegenerin 0.1 mg/kg + saline ? 100 mL). The pump was set with a background infusion rate of 2 mL/h, PCA single dose 1 mL, ...